Teladoc Health, Inc. (TDOC) — Business Overview

---

Executive Summary

Teladoc Health, Inc. is the largest pure-play virtual care company in the United States, describing itself as "the global leader in virtual care." Founded in 2002 and headquartered in Purchase, New York, the company connects members to physicians, therapists, and chronic-care programs through a technology platform that spans business-to-business (B2B) enterprise contracts and a direct-to-consumer (D2C) mental-health subscription business.

Teladoc operates through two reportable segments — Integrated Care (sold to employers, health plans, and hospitals) and BetterHelp (sold directly to consumers) — which together generated $2.53 billion in revenue in FY2025 across roughly 102 million U.S. members with access to its services and 17.1 million telehealth visits completed during the year. The company remains unprofitable on a GAAP basis, carrying a $16.4 billion accumulated deficit that is largely the legacy of its 2020 Livongo merger and subsequent goodwill write-downs, but it has turned durably free-cash-flow positive ($166.9 million in FY2025) even as its consumer mental-health franchise continues to shrink.

---

1. Core Business Model & How They Work

Teladoc effectively runs two distinct go-to-market engines under one roof — an enterprise subscription model (Integrated Care) and a consumer subscription model (BetterHelp) — that converge on the same virtual-care delivery infrastructure.

INTEGRATED CARE (B2B)                         BETTERHELP (D2C)
──────────────────────                        ─────────────────
[Employer / Health Plan      [Digital & Performance
 Signs Multi-Year Contract]   Marketing Spend Acquires
        │                     Consumer Directly]
        ▼                              │
[Per-Member-Per-Month (PMPM)           ▼
 "Access Fee" Begins Billing]  [Consumer Signs Up for
        │                      Weekly/Monthly Subscription]
        ▼                              │
[Member Activates via App/             ▼
 Portal; Benefit Is Bundled   [Matched to Licensed
 Into Employer Health Plan]    Therapist (~35,000-clinician
        │                      network) via BetterHelp /
        ▼                      BetterSleep App]
[Care Need Arises → Virtual            │
 Visit, Chronic-Care Program,          ▼
 or Connected Device Triggers  [Recurring Subscription
 "Visit Fee" / Device Revenue] Billing Continues Until
        │                      Cancellation (Churn)]
        ▼                              │
        └──────────────┬───────────────┘
                        ▼
          [Consolidated Revenue, Clinical
           Outcomes Data, and Renewal /
           Upsell Opportunity at Next
           Contract or Subscription Cycle]

Key Operational Drivers

1. Recurring Access-Fee Base: 86%+ of consolidated revenue historically comes from recurring access/subscription fees rather than one-off visit fees, giving the model SaaS-like revenue visibility layered on top of a clinical-services cost base.
2. Dual-Channel Distribution: Integrated Care is sold through long, relationship-driven enterprise sales cycles (employers, health plans, hospitals), while BetterHelp is acquired almost entirely through paid digital advertising, exposing the two segments to very different cost structures and growth sensitivities.
3. Clinician Network as Variable Cost: Rather than employing most providers directly, Teladoc contracts with a large network of physicians and licensed therapists (via its affiliated medical group, Teladoc Health Medical Group (THMG), and BetterHelp's ~35,000-clinician network), allowing capacity to flex with demand.
4. Device & Data Layer (Legacy Livongo): Connected devices — glucose meters, blood-pressure cuffs, and the Clarity monitoring platform — feed a chronic-care data loop that differentiates Integrated Care from pure video-visit competitors and supports higher per-member monetization over time.
5. M&A as a Capability-Builder: Teladoc has historically bolted on capability through acquisition — BetterHelp (2015), Livongo (2020, ~$18.5B), InTouch Health (2020), and most recently Catapult Health (closed February 2025, preventive biometric health screenings) — rather than building every capability organically.

---

2. Business Segments

Teladoc reports results through two segments that together make up substantially all consolidated revenue.

                         ┌───────────────────────────────────┐
                         │        Teladoc Health, Inc.        │
                         └──────────────────┬──────────────────┘
                                            │
                ┌────────────────────────────┴────────────────────────────┐
                ▼                                                         ▼
    ┌─────────────────────────────┐                        ┌─────────────────────────────┐
    │       Integrated Care         │                        │          BetterHelp           │
    │   (~62% of FY2025 revenue)    │                        │    (~38% of FY2025 revenue)   │
    └───────────────┬───────────────┘                        └───────────────┬───────────────┘
                    │                                                        │
    ┌───────────────┼───────────────┬───────────────┬─────────────┐          │
    ▼               ▼               ▼               ▼             ▼          ▼
Primary &       Mental Health    Chronic Care    Expert Medical  Hospital &  Direct-to-consumer
Urgent Care     (myStrength,     Management      & Specialty     Health-    online therapy
(Solo,          Wellbound EAP)   (Clarity,        Second         System     (web/app/phone/text)
Primary360)                     Chronic Care      Opinions       Tech       + BetterSleep app
                                 Complete)                       (Prism,
                                                                  Pulse)

Integrated Care (~62% of FY2025 revenue, $1,579.6M, +3% YoY)

Sold B2B to employers, health plans, hospitals, and health systems, reaching over 100 million members. Encompasses general/primary and urgent care, expert medical/specialty second opinions, mental healthcare, chronic condition management, and enterprise telehealth technology (hardware, software, and services) licensed to hospitals and health systems. This is now the segment's clear growth and margin engine, posting a 15.1% adjusted EBITDA margin in FY2025.

BetterHelp (~38% of FY2025 revenue, $950.4M, -9% YoY)

A direct-to-consumer mental-health platform connecting users to a network of nearly 35,000 licensed clinicians for online counseling and therapy, plus the adjacent BetterSleep app. Users pay recurring weekly or monthly subscription fees. The segment has been in multi-year revenue and paid-user decline (average paying users fell to 0.386 million in FY2025, down 5% YoY) as digital-advertising costs have risen and low-cost/insurance-reimbursed alternatives have proliferated.

---

3. Product Portfolio

---

4. Competitive Landscape

Teladoc's two segments face materially different competitive sets — enterprise virtual-care platforms on the Integrated Care side, and consumer mental-health apps/marketplaces on the BetterHelp side.

                           BROAD (multi-condition, whole-person care)
                                            ▲
                                            │
                                 [TELADOC HEALTH]
                                            │
                  [Included Health]         │          [Omada Health]
                                            │          [Virta Health]
     ◄───────────────────────────────────────┼───────────────────────────────────────►
     D2C / CONSUMER-LED                      │                    B2B / ENTERPRISE-LED
                                            │
      [Talkspace]  [Grow Therapy]           │          [Amwell (American Well)]
      [Headway]    [Rula]                   │          [MDLive (Cigna/Evernorth)]
      [Spring Health]                        │          [Accolade (Transcarent)]
                                            ▼
                     NARROW (single condition / mental health only)

Competitors by Domain

Integrated Care

Key Competitors: MDLive (owned by Cigna/Evernorth), Amwell (American Well Corporation), Included Health, Accolade (owned by Transcarent), Omada Health, Virta Health, and increasingly Amazon and large health plans building native virtual-care tools. Dynamics: Teladoc's advantage is breadth — one contract covering primary care, mental health, chronic care, and specialist access — versus narrower point solutions (Omada/Virta in chronic disease, Included Health in navigation). The structural threat is payer and Big Tech disintermediation: health plans and employers increasingly have the option to build or buy narrower, cheaper virtual-care capabilities rather than paying for Teladoc's full-breadth platform.

BetterHelp

Key Competitors: Talkspace, Grow Therapy, Headway, Rula, and Spring Health. Dynamics: The mental-health teletherapy market has become significantly more crowded and insurance-reimbursed since BetterHelp's rise; Headway, Grow Therapy, and Rula in particular compete by connecting consumers to therapists who bill insurance directly, undercutting BetterHelp's cash-pay subscription model on net cost to the consumer. This dynamic is the single largest driver of BetterHelp's multi-year revenue and paid-user decline.

---

5. Strategic Strengths & Risks

Competitive Strengths

• Scale and Breadth of Distribution: With access extended to roughly 102 million U.S. members and over 100 million reachable through Integrated Care alone, Teladoc has a distribution footprint few point-solution competitors can match, supporting enterprise cross-sell across service lines.
• Chronic-Care Data Asset (Livongo Legacy): The connected-device and coaching infrastructure inherited from Livongo gives Integrated Care a recurring, higher-margin revenue stream (15.1% adjusted EBITDA margin in FY2025) and a longitudinal health-data asset that is difficult for newer entrants to replicate quickly.
• Improving Free Cash Flow: Despite ongoing GAAP net losses, Teladoc generated $166.9 million of free cash flow in FY2025 on $294.4 million of operating cash flow, evidence that the underlying cash economics of the business have decoupled from its non-cash accounting losses.

Strategic Risks & Vulnerabilities

Goodwill / Intangible Impairment History
─────────────────────────────────────────────────────────────────────────
2020                    2022                     2024                 2025
Livongo merger    ───►  Billions in         ───►  $790.0M BetterHelp ─►  $71.8M
(~$18.5B,                Integrated Care           goodwill                (Catapult Health +
 all-stock)               goodwill write-downs      impairment              Telecare Australia)

1. BetterHelp's Structural Decline: BetterHelp revenue fell 9% in FY2025 (after an 8% decline in FY2024) as average paying users dropped to 0.386 million; rising paid-acquisition costs and insurance-reimbursed competitors (Headway, Grow Therapy, Rula) threaten the segment's cash-pay subscription economics further.
2. History of Large Non-Cash Impairments: Teladoc has recorded recurring, multi-hundred-million-to-billion-dollar goodwill and intangible impairments since the 2020 Livongo deal, most recently $790.0 million against BetterHelp (2024) and $71.8 million against Catapult Health and Telecare Australia (2025). The FY2025 10-K flags that the company's market capitalization fell below book value after year-end, a trigger for further goodwill-impairment testing if sustained.
3. Massive Accumulated Deficit: A $16.4 billion accumulated deficit as of year-end 2025 — overwhelmingly the legacy of Livongo purchase-accounting write-downs — constrains dividend/buyback optionality and underscores the destruction of shareholder value from past M&A.
4. Client Concentration: The top five clients represented 19% of total revenue in FY2025, exposing Integrated Care to renewal/repricing risk on a relatively small number of large enterprise relationships.
5. Regulatory & Clinical-Practice Exposure: The business depends on favorable treatment of telehealth under state licensure rules, corporate-practice-of-medicine restrictions, and DEA controlled-substance telehealth-prescribing flexibilities (particularly relevant to mental-health prescribing); any rollback of pandemic-era flexibilities is a direct risk to both segments.
6. Integration Risk from Continued M&A: The Catapult Health acquisition (closed February 2025) already generated an impairment within the same fiscal year, illustrating the execution risk inherent in Teladoc's bolt-on acquisition strategy.

---

6. Financial Overview

---

7. Summary Conclusion

Teladoc Health has evolved into a two-speed company: an increasingly profitable, scale-advantaged Integrated Care enterprise business growing low-single digits at mid-teens adjusted EBITDA margins, bolted to a BetterHelp direct-to-consumer mental-health franchise now in its third consecutive year of revenue and user decline amid intensifying, insurance-reimbursed competition.

The investment case rests on whether Integrated Care's growth, data assets, and distribution scale (102 million members) can keep outrunning BetterHelp's structural erosion — and whether management can avoid repeating the pattern of large, value-destroying goodwill write-downs that followed the 2020 Livongo merger and have recurred with BetterHelp (2024) and Catapult Health (2025). With free cash flow turning durably positive and FY2026 guidance implying broad revenue stabilization, Teladoc's near-term narrative is shifting from growth to disciplined cash generation and portfolio stabilization, even as the $16.4 billion accumulated deficit on its balance sheet remains a permanent reminder of its M&A history.